Satellite Symposium: Guiding Difficult Treatment Decisions for Transplant Recipients
Originally presented at the American Transplant Congress (ATC) 2022 in Boston.
This satellite symposium was sponsored by Eurofins Transplant Diagnostics and was not part of the ATC official educational program. The content is not endorsed by ATC.
During this panel discussion, we presented case studies of how leading physicians use biomarker guidance to improve patient outcomes in challenging and complicated contexts. We discussed practical uses of the OmniGraf® rejection biomarker panel, the inSIGHT™ t cell diagnostic assay, and other novel biomarkers, including their application in managing post-transplant patient care.
Dr. John Friedewald
Professor of Medicine (Nephrology and Hypertension) and Surgery (Organ Transplantation)
Dr. Nicolae Leca
Medical Director – Kidney and Pancreas Transplant
University of Washington Medical Center
Dr. Supahami Bunnapradist
Professor of Medicine – Nephrology
UCLA Medical Center
Dr. Gaurav Gupta
Associate Professor – Division of Nephrology
VCU Medical Center
Dr. Adnan Khan
Assistant Clinical Professor – Medicine (Nephrology)
UC San Diego